Showing results (121-130 of 194) with videos related to
Sort By:
Pageof 20
Frontiers in Immunology|May 14, 2026
Properdin deficiency or anti-properdin treatment ameliorates disease in the C3 gain-of-function mouse model of atypical haemolytic uraemic syndromeGrace Mallett, Ola Kamala, Isabel Y Pappworth, et al.Nature Genetics|August 18, 2016
Patterns of genic intolerance of rare copy number variation in 59,898 human exomesDouglas M Ruderfer, Tymor Hamamsy, Monkol Lek, et al.Molecular Immunology|August 3, 2006
Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndromeAnna Richards, M Kathryn Liszewski, David Kavanagh, et al.Immunobiology|June 9, 2016
Chromosomal rearrangement-A rare cause of complement factor I associated atypical haemolytic uraemic syndromePatrick J Gleeson, Valerie Wilson, Thomas E Cox, et al.Kidney International Reports|January 15, 2025
Efficacy and Safety of Pegcetacoplan in Kidney Transplant Recipients With Recurrent Complement 3 Glomerulopathy or Primary Immune Complex Membranoproliferative GlomerulonephritisAndrew S Bomback, Erica Daina, Giuseppe Remuzzi, et al.Journal of Medical Case Reports|May 1, 2015
Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case reportMustafa Sevinc, Taner Basturk, Tuncay Sahutoglu, et al.Journal of the American Society of Nephrology : JASN|May 27, 2005
Mutations in complement factor I predispose to development of atypical hemolytic uremic syndromeDavid Kavanagh, Elizabeth J Kemp, Elizabeth Mayland, et al.Blood|November 8, 2011
A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndromeNigel J Francis, Bairbre McNicholas, Atif Awan, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndromeViviana P Ferreira, Andrew P Herbert, Claudio Cortés, et al.Kidney Medicine|April 20, 2026
C3 Glomerulonephritis Associated With Anti-complement Factor B Antibodies Following Anti-cancer Treatment With PembrolizumabPersia Stroppou, Lucia Asaelof, Alexia Panayides, et al.Pageof 20